The Target and Mechanism of Pingxiao Capsule Against Cancer and Improving Body Immunity
DOI:
https://doi.org/10.54097/kmcypr52Keywords:
Pingxiao capsule; Chinese medicine; Tumor therapy; Anticancer mechanism; Immune enhancement.Abstract
The increasing incidence and mortality of malignant tumors pose a major threat to global health. Current treatments, such as chemotherapy and radiotherapy, are effective but can cause serious side effects to the human body. Pingxiao Capsule, a traditional Chinese medicine (TCM), has emerged as a promising alternative or adjunct therapy for cancer treatment. However, the current research on Pingxiao capsule mainly focuses on the observation of clinical efficacy, and relatively little on the basic research. This article reviewed the epidemiological characteristics of malignant tumors, the limitations of conventional treatment, and the unique advantages of Pingxiao capsule in anti-cancer and immunoenhancement therapy. The pharmacological composition, clinical application, anticancer target, mechanism of action and immunomodulatory effect of Pingxiao capsule were studied. Understanding the various benefits of Pingxiao capsule can pave the way for its wide application in clinical practice in the future. Future studies can further explore the active ingredients in Pingxiao capsule and their mechanism of action, and optimize the formulation of drugs to improve efficacy and safety.
Downloads
References
[1] Yang Yuqing, Chen Yuhuan, Li Chunxiao, et al. Effectiveness and safety of Pingxiao Capsule as adjuvant therapy in treatment of breast cancer: a systematic review and Meta-analysis [J]. Journal of Traditional Chinese Medicine, 2023, 43(5): 851-859.
[2] Qiu Rongliang, Wu Hui, Zhang Jingwei, et al. Clinical observation of the effect of Pingxiao capsule on radiotherapy and toxicity reduction of nasopharyngeal carcinoma [J]. Modern Oncology Medicine, 2005, (03): 415-416.
[3] Xie Wei, Jin Jiqiang. To observe the efficacy of Pingxiao capsule combined with chemotherapy in the treatment of digestive system malignant tumors [J]. Chinese Journal of Continuing Medical Education, 2016, 8(30): 177-178.
[4] Gu Hongzheng, Mei Qibing, Zhou Bin. Research progress of Pingxiao capsule synergistic treatment of malignant tumor [J]. World Clinical Drugs, 2015, 36(11): 789-792.
[5] Xu Ting, Shang Jin, Wang Ting, et al. Clinical effect of Toremifene combined with Pingxiao capsule on moderate and severe breast hyperplasia [J]. Clinical Medicine Research and Practice, 2019, 6(1): 35-37.
[6] Wang Juan, Yue Zhenggang, Dong Mingzhi, et al. Antitumor effect of Pingxiao capsule and its mechanism [J]. Chinese Journal of Traditional Chinese Medicine, 2017, 32(10): 4658-4663.
[7] Hu Junfeng, Chen Tao. Research progress on the extraction of active components from Herba argentiana and their antitumor effects [J]. Bachu Med, 2022, 5(2): 118-121.
[8] Guo Yuyan, Li Chuncheng, Sun Shuang, et al. Study on anti-tumor mechanism of Strychnine based on network pharmacology [J]. Chinese Journal of Traditional Chinese Medicine, 2022, 37(4): 844-849.
[9] Chen Hongxiao, Liu Su, Jin Le, et al. Study on the mechanism of Pingxiao capsule promoting apoptosis of breast cancer through AKT1/β-catenin signal based on network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 28(12): 1321-1330.
[10] Wu Qiong, Xue Qian, Wu Maoyong, et al. Effect of Pingxiao capsule combined with SOX regimen in the treatment of advanced gastric cancer and its influence on TGF-α and ARK5 levels in peripheral blood [J]. Drug Evaluation Research, 2019, 44(07): 1495-1501.
[11] Zhu Qinggui. Molecular biological mechanism of Pingxiao capsule against lung cancer [J]. Journal of Southern Medical University, 2008, (11): 2069-2071.
[12] Han L, Wang JN, Cao XQ, Sun CX, Du X. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis [J]. Biomed Pharmacother, 2018, 108: 941-951.
[13] Gu Jianfa. Effect of Pingxiao capsule on patients with advanced gastric cancer treated by chemotherapy [J]. Henan Medical Research, 2017, 26(08): 1418-1419.
[14] Wang Lichen, Chen Zhen, Tang Wenbing, et al. Clinical effect of neoadjuvant chemotherapy combined with Pingxiao capsule in the treatment of oral squamous cell carcinoma and expression of microRNA [J]. Modern Hospital, 2018, 18(01): 112-116.
[15] Gu Muren. Pingxiao capsule combined with conventional radiation and chemotherapy: clinical observation on treatment of lung cancer [J]. Journal of New Traditional Chinese Medicine, 2015, 47(12): 179-180.
[16] Cai Jufen, Sun Lin, Xu Nong, Guo Genfa. Report of 40 cases of advanced lung cancer treated by Pingxiao capsule combined with anticancer drugs [J]. Zhejiang Oncology, 1995, (03): 168-169.
[17] Perez E C, Xander P, Laurindo M F L, et al. The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes [J]. PLoS One, 2017, 12(11): e0187333.
[18] Xiang Mei, Wei Xiaoli. Clinical study of Pingxiao capsule combined with FOLFOX4 regimen in the treatment of colorectal cancer [J]. Modern Medicine & Clinic, 2015, 30(06): 700-705.
[19] Ha Hong. Clinical study of Pingxiao capsule combined with alamrelin in the treatment of uterine fibroids [J]. Modern Medicine and Clinic, 2019, 34(04): 1090-1094.
[20] Tang Tianle, Sun Yang, Li Yuhua, et al. Pharmacodynamics of Pingxiao capsule on mammary hyperplasia model rats [J]. Journal of Central South Pharmacy, 2019, 18(11): 1837-1841.
[21] Zhong Hailin, Cai Lin, Sun Yang, et al. Effect of Pingxiao capsule on experimental breast cancer [J]. Chinese Journal of Breast Diseases (Electronic Edition), 2019, 15(02): 82-89.
[22] Han Xiaorong, Yang Jianmin, Luo Yizhong, et al. Effect and mechanism of Pingxiao capsule on the prevention of breast cancer in experimental rats [J]. Chinese Journal of Breast Diseases (Electronic Edition), 2013, 7(05): 329-333.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
